2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzothiazole
Structure Info
- Chemspace ID
- CSSB21332146475 (In-Stock Building Blocks)
- IUPAC Name
- 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzothiazole
- Mol formula
- C16H15Cl2N5S
- Mol weight
- 380 Da
- Catalog Number(s)
- BBLS21332146475, EN300-55006080, bbls21332146475
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.51
- Heavy atoms count
- 24
- Rotatable bond count
- 2
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.375
- Polar surface area (Å)
- 55
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 0
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzothiazole (C16H15Cl2N5S) - CSSB21332146475](/st/structure/200/811cceca4622ed82613390c835f39c3b/CC1%253DCC2%253DC%2528SC%2528%253DN2%2529C2CCN%2528CC2%2529C2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529C%253DC1.png "C16H15Cl2N5S")
- Zoom the structure
- CSSB21332146475
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 611.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 640.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 670.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 699.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 727.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,428.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,110.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 3,130.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-fluoro-1,3-benzothiazole - CSSB21332127209](/st/structure/200/ce00e20d62e96b59d3d7732901a4c79d/FC1%253DCC2%253DC%2528SC%2528%253DN2%2529C2CCN%2528CC2%2529C2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529C%253DC1.png)
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-1,3-benzothiazole - CSSB21332145761](/st/structure/200/cd70c3936d85aac88abe0490cc0b061a/ClC1%253DNC%2528%253DNC%2528Cl%2529%253DN1%2529N1CCC%2528CC1%2529C1%253DNC2%253DC%2528S1%2529C%253DCC%253DC2.png)
![Chemical structure of 2-[1-(4,6-dichloro-1,3,5-triazin-2-yl)piperidin-4-yl]-5-methyl-1,3-benzoxazole - CSSB21332070393](/st/structure/200/f89814b778b2ef6690d7d284975611d5/CC1%253DCC2%253DC%2528OC%2528%253DN2%2529C2CCN%2528CC2%2529C2%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN2%2529C%253DC1.png)
![Chemical structure of 1-[4-(5-methyl-1,3-benzothiazol-2-yl)piperidin-1-yl]ethan-1-one - CSSB15078384605](/st/structure/200/6d8a10309aa75f5bfa29755b454ef029/CC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNC2%253DCC%2528C%2529%253DCC%253DC2S1.png)
